Access the world's leading research and resources to help you navigate decisions and adapt strategy as the pandemic evolves.
Life science companies are racing to develop treatments while delivering needed therapeutics to their existing patients–all while adjusting to unpredictable, rapidly-changing market environments.
This interactive tool was developed by Clarivate analysts with expertise in epidemiology, real world data and medtech, using our claims and Real World Data* data-sets. To ensure you have the most up-to-date information, Clarivate refreshes this data weekly. COVID-19 exposed and diagnosed patient tracking is based on health system documented exposure or potential exposure, and confirmed diagnosis aligned to ICD-10-CM official coding and reporting guidelines.
Select the tabs in the dashboard below to toggle between views.
This dashboard combines data from the following internal and external sources: